Animal cell technology is now widely used in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies. The quality of the cell culture determines the quality of the final product. The aim of iCONSENSUS is to achieve a faster, safer and more cost-effective process for the development and manufacture of these products. Among other things, the project will develop innovative analytical, hardware, software and high-throughput tools for the development, monitoring and control of mammalian cell cultivation processes for producing biopharmaceuticals.
iCONSENSUS
Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production
FACTS & FIGURES
| Start Date |
|
| End Date |
|
| Call |
IMI2 - Call 10
|
| Grant agreement number |
777397
|
Type of Action:
RIA (Research and Innovation Action)
| Contributions | € |
|---|---|
| IMI Funding |
4 700 000
|
| EFPIA in kind |
4 700 000
|
| Total Cost |
9 400 000
|
Summary
Participants Show participants on map
EFPIA companies
- Bayer Aktiengesellschaft, Leverkusen, Germany
- Byondis BV, Nijmegen, Netherlands
- Glaxosmithkline Research And Development LTD., Brentford, Middlesex, United Kingdom
- Pfizer Limited, Sandwich, Kent , United Kingdom
- Rentschler Biopharma Se, Laupheim, Germany
- Sanofi-Aventis Deutschland GMBH, Frankfurt / Main, Germany
- UCB Biopharma, Brussels, Belgium
Universities, research organisations, public bodies, non-profit groups
- Kungliga Tekniska Hoegskolan, Stockholm, Sweden
- Rheinisch-Westfaelische Technische Hochschule Aachen, Aachen, Germany
- Universitaet Hohenheim, Stuttgart, Germany
- Universite De Mons, Mons, Belgium
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
- Iprasense, Clapiers, France
- Ipratech SA, Mons, Belgium
- Kantisto BV, Baarn, Netherlands
- Micronit BV, Enschede, Netherlands
- Paia Biotech GMBH, Köln, Germany
- Presens Precision Sensing GMBH, Regensburg, Germany
Associated partners
- Ramcon A/S, Birkerod, Denmark
Non EFPIA companies
- Beckman Coulter GMBH, Krefeld, Germany
| Participants | |
|---|---|
| Name | IMI funding in € |
| Iprasense | 71 000 |
| Ipratech SA | 150 000 |
| Kantisto BV | 308 500 |
| Kungliga Tekniska Hoegskolan | 1 414 354 |
| M2p-Labs GMBH (left the project) | 263 161 |
| Micronit BV | 206 934 |
| Micronit Holding BV (left the project) | 469 066 |
| Paia Biotech GMBH | 250 000 |
| Presens Precision Sensing GMBH | 454 000 |
| Rheinisch-Westfaelische Technische Hochschule Aachen | 374 000 |
| Svanholm.Com Aps (left the project) | 83 485 |
| Universitaet Hohenheim | 355 500 |
| Universite De Mons | 300 000 |
| Total Cost | 4 700 000 |
Project leader
Luc Kupers
Sanofi
Luc Kupers
Sanofi
LINKS AND DOCUMENTS
Project website
https://www.iconsensus.eu/